Gene Bridges licenses Red/ET recombineering to Genencor
German recombineering company Gene Bridges has completed a commercial license agreement with Genencor International USA, a part of Danisco US, for the use of Gene Bridges" Red/ET recombination technology.
German recombineering company Gene Bridges has completed a commercial license agreement with Genencor International USA, a part of Danisco US, for the use of Gene Bridges" Red/ET recombination technology.
Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant micro-organisms for use in industrial applications. No financial details were disclosed.
"We are pleased to add Danisco to the list of major industrial biotechnology companies using Red/ET," said Gary Stevens, ceo of Gene Bridges. "Recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia."
Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome. According to Gene Bridges, recombineering DNA using Red/ET has a number of advantages over conventional methods:
- Independent of restriction sites
- No size limits
- No unwanted mutations
- Rapid